Skip to main content
OpenTrials
Completed

NCT Number: NCT04310280

Effects of Local Insulin on Varicose Ulcers for Wound Healing

A randomized, split-plot, double-blind, placebo-controlled trial. The varicose ulcer is divided into two (side A and B). Half of the wound's surface is treated locally with insulin (Glargine) applied at an approx depth of 3-4 mm. Treatment with insulin is administered for 7 days. Biopsy specimens of the two sides are obtained on days 0 and 7. A thermographic photograph of the wound is taken at days 0 and 7. The number of blood vessels and fibroplasia is evaluated as the main outcome.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Mario Aurelio Martínez-Jiménez

San Luis Potosí City, San Luis Potosí, 78220, Mexico

About this study

A randomized, split-plot, double-blind, placebo-controlled trial. Chronic Varicose Ulcers measuring more than 4 cm in any of its dimensions, and that comply with candidate criteria are included in the present study. A split-mouth model is used.

The ulcer is divided into two (sides A and B). The side in which treatment is applied is randomized. Half of the wound's surface is treated locally with insulin (Glargine) applied at an approx depth of 3-4 mm. Both halves are covered with dressings and compression therapy is applied. Treatment with insulin is administered for 7 days. Biopsy specimens of the two sides are obtained on days 0 and 7. A thermographic photograph of the wound is taken at days 0 and 7, as control of the local temperature of the wound. This is to asses the process of healing and to correlate with our outcome measures. The number of blood vessels will be evaluated as the main outcome. Fibroplasia and thermal asymmetry between wound sides will be evaluated as secondary outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any gender
  • Presence of varicose ulcer in lower extremities with a size greater than 25 cm2
  • Absence of infection

Exclusion criteria

  • Presence of diabetes or glycated hemoglobin >6.5%
  • Comorbidities that affect wound healing
  • Malnutrition
  • Active smoking

Treatment and study plan

insulin glargine

Drug

Half of the wound surface is injected daily with topical glargine insulin

Saline

Drug

Half of the wound surface is injected daily with topical saline solution

Primary outcomes

  1. Final angiogenesis

    Time frame: Day 7

    Number of blood vessels in a skin biopsy

Secondary outcomes

  1. Fibroplasia

    Time frame: Day 7

    Percentage of fibrous tissue in a skin biopsy

  2. Thermal asymmetry

    Time frame: Day 7

    Difference between the temperature of the wound and the surrounding healthy tissue

  3. Hypoglycaemia

    Time frame: Day 7

    Presence of capillary blood glucose of <60 mg/dl or clinical symptoms of hypoglycemia

Sponsors and collaborators

Lead sponsor

Hospital Central "Dr. Ignacio Morones Prieto"

Other

Registry information

Official study title

Effects of Local Insulin on Wound Angiogenesis and Fibroplasia in Varicose Ulcers

Important dates

Study start
2019
Primary completion
2019
Study completion
2020
First posted
Mar 17, 2020
Registry last updated
Mar 17, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.